These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37230521)

  • 1. Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study.
    Fishbane S; Jadoul M; Dember L; Kovesdy CP; Al-Shurbaji A; Lisovskaja V; Sekar P; Katona B; Guzman N; Herzog C
    BMJ Open; 2023 May; 13(5):e071309. PubMed ID: 37230521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
    Ni Z; Lu R; Xu X; Bian X; Zhou Z; Yang J; Luo Q; Chen M; Chen C; Sun X; Yu L; He Q; Jiang H; Yuan W; Li Y; Zhou R; Wang J; Zhang X; Zuo L; Meng X; Chang Z; Zhao J; Wessman P; Xiang P;
    Clin Ther; 2023 Jul; 45(7):633-642. PubMed ID: 37385905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    BMC Nephrol; 2022 Feb; 23(1):59. PubMed ID: 35135481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study.
    Zannad F; Hsu BG; Maeda Y; Shin SK; Vishneva EM; Rensfeldt M; Eklund S; Zhao J
    ESC Heart Fail; 2020 Feb; 7(1):54-64. PubMed ID: 31944628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
    Roger SD; Lavin PT; Lerma EV; McCullough PA; Butler J; Spinowitz BS; von Haehling S; Kosiborod M; Zhao J; Fishbane S; Packham DK
    Nephrol Dial Transplant; 2021 Jan; 36(1):137-150. PubMed ID: 32030422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocol.
    Shen N; Meng Q; Zhang L; Xie H; Zhao J; Xing C; Zuo L; Long G; Zhu Q; Shan C; Cai X; Yang J; Luo X; Wang J; Ye J; Wan X; Tian S; Wu Y; Lin Y; Yu X; Li Q; Liu X; Shi Z; Zhou J; Liu C; Cao Y; Wang N; Jiang X; Wu H; Hu Y; Li L; Wang Z; He J; Cao J; Wu F; Ma C; Yin X; Li Z; Wang H; Lin H
    BMJ Open; 2023 Mar; 13(3):e070530. PubMed ID: 36889826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zhang L; Yao L; Shao G; Zuo L; Qin S; Zhang X; Zhang Q; Yu W; Luo Q; Ren Y; Peng H; Xiao J; Yang Q; Chen Q; Shi Y;
    BMC Nephrol; 2023 Aug; 24(1):233. PubMed ID: 37559023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zuo L; Yu W; Ren Y; Yang Q; Xiao J; Zhang Q; Zhang L; Zhang X; Chen Q; Chen C; Shao G; Luo Q; Yao L; Qin S; Peng H; Zhao Q;
    BMJ Open; 2021 Dec; 11(12):e055770. PubMed ID: 34937724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol.
    ; ; . PubMed ID: 37734899
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.